Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Nanoviricides, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 36 | 37 | +1 |
| Shares | 1.46M | 1.49M | +28.0K (+1.9%) |
| Value | $2.09M | $1.74M | −$348.6K (−16.7%) |
New holders (3)
Institutions that held Nanoviricides, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 51,252 | $60.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 22,138 | $25.9K | 0.00% |
| JPMorgan Chase & Co | 26 | $30 | 0.00% |
Sold out (2)
Institutions that held Nanoviricides, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 22,252 | $31.8K |
| FMR LLC | 86 | $123 |